Aflac

Aflac

Supplemental health and life insurance provider

Overview

Aflac provides supplemental health and life insurance products to individuals and families, operating mainly in two regions: Aflac Japan and Aflac U.S. Its policies are designed to cover out-of-pocket costs from health events and income loss, including cancer, critical illness, accidents, hospital stays, and life events. These benefits are paid directly to policyholders to help manage medical expenses not fully covered by primary insurance. The products are distributed through a network of independent agents, brokers, and financial advisors, enabling a high-volume, low-premium model that supports a large, stable customer base and ongoing revenue. Japan is its largest market, and the company uses this broad distribution and scale to differentiate itself from competitors. The goal is to provide straightforward financial protection against unexpected health-related costs while expanding its presence in the U.S. and Japanese markets.

Funded Recently

About Aflac

Simplify's Rating
Why Aflac is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Financial Services

Healthcare

Company Size

10,001+

Company Stage

IPO

Headquarters

Columbus, Georgia

Founded

1955

Simplify Jobs

Simplify's Take

What believers are saying

  • Japan sales rose 25.5% in Q1 2026, driven by new medical products.
  • U.S. group voluntary and absence disability sales grew over 12% year over year.
  • May 2026 yen bonds provide cheaper funding for Japanese operations and capital returns.

What critics are saying

  • Japan lapses are suppressing earned premiums and keeping near-term growth negative.
  • Core U.S. agent-driven sales are flat, leaving legacy distribution momentum weak.
  • Four straight years of operating cash flow decline threaten buybacks and dividend flexibility.

What makes Aflac unique

  • Japan generates 53.36% of revenue, giving Aflac concentrated scale.
  • Aflac leads U.S. supplemental health with 27% workplace benefit market share.
  • Its portfolio spans cancer, accident, critical illness, hospital, disability, and life insurance.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$3.6B

Above

Industry Average

Funded Over

3 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Hybrid Work Options

Remote Work Options

Stock Price

Company News

Yahoo Finance
Feb 25th, 2026
Aflac misses Q4 revenue estimates as life insurance stocks slip 5.6%

Life insurance stocks reported a slower fourth quarter, with the 13 companies tracked beating revenue consensus estimates by 3.7% on average. However, share prices have declined 5.6% on average since the latest earnings results. Aflac reported revenues of $4.28 billion, flat year on year, missing analysts' expectations by 2.9%. The company also missed earnings per share estimates. CEO Daniel Amos said the results reflect focused efforts to create long-term shareholder value. The stock has remained flat since reporting and currently trades at $112.80. Corebridge Financial performed best in the quarter, reporting revenues of $6.34 billion, up 35.7% year on year and beating expectations by 47.3%. The company also exceeded earnings per share estimates.

Yahoo Finance
Feb 4th, 2026
Aflac reports Q4 net earnings of $1.4B, announces 5.2% dividend increase

Aflac Incorporated reported fourth quarter net earnings of $1.4 billion, or $2.64 per diluted share, down from $1.9 billion, or $3.42 per share, in the same period last year. Total revenues fell to $4.9 billion from $5.4 billion year-over-year. Adjusted earnings decreased 5.4% to $818 million, though adjusted earnings per diluted share rose 0.6% to $1.57. Net earnings included investment gains of $537 million, driven primarily by gains on derivatives and foreign currency activities. Shareholders' equity stood at $29.5 billion, or $56.85 per share, at year-end. For full-year 2025, net earnings totalled $3.6 billion with adjusted earnings of $4.0 billion. The company reaffirmed a 5.2% increase in its first quarter dividend.

Cbonds
May 28th, 2025
Aflac: Other Events, Financial Statements And Exhibits

01 Other Events.

MarketBeat
Jan 6th, 2024
BluePath Capital Management LLC Makes New Investment in Aflac Incorporated (NYSE:AFL)

BluePath Capital Management LLC purchased a new position in Aflac Incorporated (NYSE:AFL - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 66,732 shares of the financial

Slater Sentinel
Dec 3rd, 2023
Eqis Capital Management Inc. Makes New Investment in Aflac Incorporated (NYSE:AFL)

Eqis Capital Management Inc. purchased a new position in shares of Aflac Incorporated (NYSE:AFL – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 12,152 shares of the financial services provider’s stock, valued at approximately $848,000. Several other large investors […]

Recently Posted Jobs

Sign up to get curated job recommendations

Aflac is Hiring for 26 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →